NCT00051181已完成3 期
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 3
研究概览
简要总结
To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%) is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure glaucoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (3)
Loading locations...
相似试验
已完成
4 期
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular HypertensionGlaucomaNCT00763061Alcon Research111
已完成
4 期
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension GlaucomaNormal Tension GlaucomaOcular HypertensionNCT01995136Alcon Research32
已完成
3 期
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Glaucoma, Open-AngleOcular HypertensionNCT00051142Alcon Research
已完成
4 期
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololGlaucomaNCT01336569Alcon Research50
已完成
3 期
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsPediatric GlaucomaElevated IOP in Pediatric PatientsOcular Hypertension in Pediatric PatientsNCT01652664Alcon Research184